The atypical urothelial cancer patient: management of bladder cancers of non-transitional cell histology and cancers of the ureters and renal pelvis.
Non-transitional cell neoplasms of the bladder and upper tract transitional cell carcinomas (ureter and renal pelvis) represent only a small fraction of urothelial carcinomas. Clinicians faced with the rare case are always confronted with management dilemmas complicated by the scarcity of published experience to guide decisions. The current review brings together the best of the limited published data in an attempt to provide some reasonable context to help in the management of these difficult neoplasms.
Gilligan
Timothy
T
Department of Solid Tumor Oncology, Taussig Cancer Center, and Glickman Urologic Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Dreicer
Robert
R
D000230:Adenocarcinoma / Q000628:therapy; D018288:Carcinoma, Small Cell / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D006801:Humans; D007680:Kidney Neoplasms / Q000628:therapy*; D007682:Kidney Pelvis; D012553:Schistosomiasis haematobia / Q000150:complications; D014497:Urachus; D014516:Ureteral Neoplasms / Q000628:therapy*; D001749:Urinary Bladder Neoplasms / Q000469:parasitology / Q000628:therapy*